We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...

Data fragmentation and inefficiency are most evident in the quality reporting approach currently used for accountable care organizations by the Centers for Medicare and Medicaid Services—the ...

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.

A 2026 CMS proposed rule contains multiple provisions that will improve the transparency of hospital prices and support the ...

The No UPCODE Act—with some refinements—is a good start insofar it establishes some key pieces of reform, but a broader ...

With collaboration and evidence-based approaches, we can build a patient-centric health care system that works better for ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

The real gold standard for science, and academic freedom, requires upholding scientific work that investigates who and what ...

Abandoning a universal recommendation, in place since 2021, in favor of shared clinical decision making for everyone. This ...